OBJECTIVE:
It is fundamentally challenging to predict which bacteria will cause disease or function as harmless commensal organisms. One example is Group B Streptococcus (GBS), which fewer than 0.4/ 1000 will cause invasive early sepsis in neonates. A commensal in adults, GBS colonization of the vagina or rectum occurs in an estimated 10-30% of pregnant women. Given that thousands of women will be exposed to antibiotics to prevent a single case of newborn GBS sepsis, we aimed to determine if the co-occurrence of GBS with other species of the vaginal microbiome could help explain the disparity between maternal prevalence (10-30%) and early invasive newborn disease (<0.02% at baseline, currently <0.004%). STUDY DESIGN: Whole genome shotgun sequencing was performed on vaginal samples (n¼201) collected from 60 gravidae during 3rd trimester, delivery, and 4-6 weeks postpartum. All subjects underwent culture-based GBS screening at 36 weeks. Metagenomic classification was performed using MetaPhlAn2 and Centrifuge. BWA was used to map sequence reads to the GBS reference genome 2603V/R. RESULTS: Metagenomics identified GBS in 4/5 and 50/55 subjects with a positive or negative clinical culture, respectively. There was no significant difference in the relative abundance of GBS based on clinical culture status (p>0.05). On average, GBS-classified samples had a two-fold increased genomic coverage compared to samples classified without (Fig.1A) . Markov chain modeling of GBS status demonstrated that GBS positive subjects are likely to remain positive at subsequent timepoints (Fig.1B) . Probabilistic modeling to examine species co-occurrence revealed numerous significant associations (Fig.1C) . A majority represented positive co-occurrences, including with L. iners. Interestingly, a negative co-occurrence was identified with L. crispatus, including at delivery (Fig.1D) .
CONCLUSION:
Our findings are of marked significance as they demonstrate that GBS is a more common commensal in the vagina than previously estimated. We further establish via Markov modeling a high probability of becoming/staying GBS positive and that keystone vaginal species negatively co-occur with GBS, including with L.crispatus, which has a known protective role in vaginal health. Although we had no cases of neonatal GBS disease in our cohort, future studies leveraging our novel observations may have implications for risk modification or tailoring of indications for GBS prophylaxis in labor.
655 Tenofovir to prevent mother-to-child transmission of hepatitis B virus: systematic review with meta-analysis were searched for the following terms: "tenofovir", "hepatitis B", and "pregnancy" from inception of each database until August 2018. No language restrictions were applied. We included all prospective comparative trials of tenofovir administration vs. controls for pregnant patients with chronic hepatitis B infection assessing mother to child transmission rates. The primary outcome was newborn HBsAg positivity at 6-9 Months. Meta-analysis was performed using a random effects model to produce summary treatment effects in terms of odds ratio, with 95% confidence intervals. Heterogeneity was measured using Chi-square and I 2 statistics. The quality of the evidence was assessed using the Cochrane Risk of Bias assessment tool. Data analysis was conducted with Review Manager v. 5.3. RESULTS: Five studies (two randomized controlled trials, three nonrandomized controlled trials) that enrolled 813 women were included. The results from comparative trials showed that maternal treatment with tenofovir did not significantly reduced the risk of infant hepatitis B surface antigen seropositivity between 6-9 months of age (odds ratio ¼ 0.39, 95% confidence intervals ¼ 0.10, 1.50, P ¼ 0.17) I2 44%. CONCLUSION: For pregnant women with hepatitis B virus, tenofovir administration did not prevent mother to child transmission when combined with hepatitis B immunoglobulin and the hepatitis B vaccine. Further well-designed RCTs are necessary to confirm the findings of this study. OBJECTIVE: Acute funisitis (AF) has been shown to be part of the fetal inflammatory response seen in association with acute chorioamnionitis (AC) and ascending infection. However, the significance of AF seen in isolation is not known. The objective of this study was to evaluate clinical and pathologic features of cases of isolated AF in order to determine the significance of this finding and how it can contribute to our understanding of adverse clinical outcomes. STUDY DESIGN: This was a retrospective review of third trimester placentas of patients who delivered at our institution from 1997-2017. Our institution's surgical pathology database was searched for third trimester placentas with the diagnosis of AF without a diagnosis of AC. Placentas without AF or AC were controls and placentas with AF but without AC were cases. RESULTS: There were 156 cases and 183 controls identified. Maternal age, gestational age, birthweight, mode of delivery and Apgar scores were similar in both groups. There was no increase in histologic lesions associated with maternal vascular malperfusion, fetal vascular malperfusion, cord complications or chronic villitis. In the cases, 132 (84.6%) of had meconium in fetal membranes, and of those, 70 (44.9%) also had meconium in the umbilical cord. 34(21.8%) of those with meconium in the umbilical cord also had myonecrosis. In the controls, 72(39.3%) had meconium in fetal membranes, and of those, 8(5.1%) also had meconium in the umbilical cord. 5(2.8%) of those with meconium in the umbilical cord also had myonecrosis. When comparing the presence of meconium in the membranes, meconium in the cord and myonecrosis in the cases and controls, all comparisons were found to be significant (84.6% vs 39.3%, p¼<.00001, 44.9% vs 5.1%, p ¼ <.0001 and 21.8% vs 2.75%, p ¼<.00001, respectively). CONCLUSION: AF can be indicative of placental abnormalities other than AC. There is a strong association between AF without AC and the presence of meconium, particularly in the umbilical cord. As meconium can be associated with myonecrosis of umbilical vessels, in some cases AF may be the result of damage to the muscle fibers of the cord rather than an ascending infection.
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